LT - CRYSTALLINE FORMS OF (3 S) -3- [N- (N` - (2-TERT-BUTYLPHENYL) OXAMYL) ALANINYL] AMINO-5- (2 `, 3 `, 5 `, 6 ` -TETRAFLUORO PHENOXY) -4-OXOPENTA NOIC ACID
EN - CRYSTALLINE FORMS OF (3 S) -3- [N- (N` - (2-TERT-BUTYLPHENYL) OXAMYL) ALANINYL] AMINO-5- (2 `, 3 `, 5 `, 6 ` -TETRAFLUORO PHENOXY) -4-OXOPENTA NOIC ACID
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07C 237/22 |
|
|
|
A61K 31/197 |
|
|
|
A61P 1/16 |
|
European patent
(11) |
Number of the document |
2091910 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
07859033.8 |
|
Date of filing the European patent application |
2007-12-03 |
(97) |
Date of publication of the European application |
2009-08-26 |
(45) |
Date of publication and mention of the grant of the patent |
2014-08-20
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/IB2007/003900 |
|
Date |
2007-12-03 |
PCT application publication
(87) |
Number |
WO 2008/068615 |
|
Date |
2008-06-12 |
Priority applications
(30) |
Number |
Date |
Country code |
|
868748 P |
2006-12-06
|
US |
Inventors
(72) |
DIMOCK, Stuart, US
HAGEN, Eric, US
HANKO, Jason, US
|
Grantee
(73) |
Conatus Pharmaceuticals, Inc.,
16745 W. Bernardo Drive, Suite 200, San Diego, CA 92127,
US
|
Title
(54) |
CRYSTALLINE FORMS OF (3 S) -3- [N- (N` - (2-TERT-BUTYLPHENYL) OXAMYL) ALANINYL] AMINO-5- (2 `, 3 `, 5 `, 6 ` -TETRAFLUORO PHENOXY) -4-OXOPENTA NOIC ACID |
|
CRYSTALLINE FORMS OF (3 S) -3- [N- (N` - (2-TERT-BUTYLPHENYL) OXAMYL) ALANINYL] AMINO-5- (2 `, 3 `, 5 `, 6 ` -TETRAFLUORO PHENOXY) -4-OXOPENTA NOIC ACID |